Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Chronic Pain × Naltrexone × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Substance Withdrawal Syndrome 1 Chronic Pain 1

Interventions

Morphine 3 Fentanyl 2 morphine, naltrexone combination 1 Oxycodone 1 Naltrexone 1 Methadone 1 Dexmedetomidine 1 Buprenorphine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01100437 2012-07-13

Safety Study to Assess Opiate Withdrawal Signs and Symptoms in Opioid Dependent Patients

Pfizer

Phase 4 Terminated

14 enrolled 18 charts

Substance Withdrawal Syndrome, Chronic Pain

Data powered by HemOnc (CC BY 4.0) Colophon ⚡